Max Robotics — Global Service Robot Directory + US Certification

About

Scott Eggener is a leading urologic oncologist whose research has fundamentally shaped the modern management of prostate and kidney cancers. His work is centered on improving diagnostic accuracy and surgical outcomes, particularly through the refinement of biopsy techniques and nephron-sparing surgery. Eggener’s seminal paper on “Imaging-guided Prostate Biopsy” (99 citations) critically analyzed the limitations of standard transrectal ultrasound-guided biopsies and championed the adoption of MRI-targeted approaches, a shift that has become a new standard of care. He has also made pivotal contributions to kidney cancer surgery, with his study on “Differential Use of Partial Nephrectomy” (38 citations) explaining the wide variability in utilization rates by accounting for tumor complexity, thereby providing a crucial framework for evaluating surgical quality. Further demonstrating his impact, Eggener has investigated risk factors for complications like rectal injury during prostatectomy and has explored innovative techniques to preserve erectile function, such as nerve bundle hydrodissection. Through these high-impact studies, Eggener has directly influenced clinical guidelines and surgical practice, making him a key figure in advancing precision and safety in urologic oncology.